The Ventana TROP2 RxDx Device, a computational companion diagnostic, was granted breakthrough device designation by the FDA ...

Roche has claimed a breakthrough designation from the FDA for a cancer test that combines an antibody assay with artificial ...

RxDx Device for non-small cell lung cancer has received Breakthrough Device Designation from the U.S. Food and Drug ...

Mao and her colleagues evaluated pathology samples and data on mutations from 164 patients with early lung adenocarcinoma. Specifically, chromatin structure analysis was performed on lung tissue ...